A comprehensive guide to BPC-157 dosing, reconstitution, and how to use your labs to dial in the optimal protocol for healing and recovery.
What Is BPC-157? BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. With 15 amino acids, it is one of the most studied healing peptides in the research literature, with over 180 PubMed publications as of 2025. Unlike many peptides that target a single pathway, BPC-157 works through multiple overlapping mechanisms: nitric oxide signaling, VEGF-mediated angiogenesis, growth factor upregulation, and direct anti-inflammatory activity.
**Typical range:** 250–500 mcg per injection
**Frequency:** Once or twice daily
**Route:** Subcutaneous (SQ) injection near the site of injury, or systemic (abdominal SQ)
**Cycle:** 4–12 weeks, followed by an equal off period
For systemic healing goals — gut integrity, general tissue repair, and cardiovascular support — abdominal subcutaneous injection works well. For localized injuries (tendons, ligaments, muscle tears), injecting near the affected area appears to enhance local effects.
BPC-157 arrives lyophilized (freeze-dried powder). Use bacteriostatic water (BAC water) for reconstitution.
**Example:** 5mg vial + 2mL BAC water = 2,500 mcg/mL concentration
At 250 mcg/dose: draw **10 units** on an insulin syringe
At 500 mcg/dose: draw **20 units** on an insulin syringe
Use the MyProtocolStack reconstitution calculator to get exact units for your vial size and target dose.
While BPC-157 doesn't have a direct serum marker, several lab panels can guide your protocol:
**hs-CRP (high-sensitivity C-Reactive Protein)**
The best indirect marker for BPC-157's anti-inflammatory effect. Optimal range: <1.0 mg/L. If your hs-CRP is elevated (>2.0), BPC-157's anti-inflammatory pathway is likely where you'll feel the most benefit.
**IGF-1**
BPC-157 upregulates growth hormone receptors and growth factor signaling. Baseline IGF-1 is useful context — lower IGF-1 users often report faster subjective recovery improvement.
**Gut markers (if applicable)**
If using BPC-157 for gut healing (leaky gut, IBD, NSAID damage), track symptoms + stool calprotectin if accessible.
BPC-157 pairs exceptionally well with TB-500 (thymosin beta-4 fragment). BPC-157 drives angiogenesis — new blood vessel formation — while TB-500 drives cell migration to damaged tissue. Together they form the Wolverine Stack, providing complementary healing that each peptide can't achieve alone.
Adding GHK-Cu creates the Glow Stack, adding collagen synthesis and copper-mediated extracellular matrix remodeling.
BPC-157 has a remarkably clean safety profile in both animal studies and extensive anecdotal human use. No serious adverse effects have been reported at therapeutic doses. The most common side effects reported are mild nausea (usually dose-related) and injection site reactions.
**Not for use during pregnancy or in individuals with active cancer** — its pro-angiogenic properties are contraindicated in cancer.
Use MyProtocolStack to log every injection, track your hs-CRP across lab draws, and run StackAI analysis on your full panel to identify whether BPC-157 fits your specific biology. Your numbers guide your protocol — not generic dosing charts.
Enter your blood work in MyProtocolStack, run StackAI analysis, and get personalized insights based on your actual numbers — not generic charts.
Start Free →